Apellis Pharmaceuticals, Inc. (APLS) has 12 identified peers for comparison in the Healthcare sector. Peers include ABOS, AKRO, AMLX, BPMC, CERE, DAWN and others.
APLS has a market capitalization of $5.22B, compared to an average peer market cap of $4.69B.